New Delhi: Drug major CiplaBSE -0.90 % on Wednesday reported a 43.85 rise in consolidated net profit at Rs 374.83 crore from Rs 26.57 crore posted for the corresponding quarter of last financial year.
Analysts in an ETNow poll had projected Rs 350 crore profit for the quarter.
The pharma company posted Rs 3,647.21 crore revenue against Rs 3,770 crore estimate made in an ETNow poll. Total revenue stood at Rs 3,150 crore in the year-ago quarter.
Margins came in at 18.5 per cent compared with estimates of 18 per cent. The company had reported an Ebitda of Rs 677 crore for the period under review.
In a regulatory filing to the stock exchanges, the drug firm said its tax expenses during the quarter rose to Rs 128.27 crore from Rs 50.34 crore in the year-period.